The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during ?-interferon therapy

Yalcin, KDegertekin, HYurdaydin, CBozdayi, MBozkaya, H2024-04-242024-04-2420030954-691Xhttps://doi.org/10.1097/01.meg.0000059154.68845.d4https://hdl.handle.net/11468/17249[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessChronic Hepatitis DHepatitis B VirusExacerbationAlpha-InterferonThe role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during ?-interferon therapyThe role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during ?-interferon therapyArticle157819823WOS:0001842390000152-s2.0-00378258301281131410.1097/01.meg.0000059154.68845.d4Q2Q3